Skeletal response to teriparatide in real-life setting: effects of age, baseline bone density and prior denosumab use.

TPD-induced changes in BMD at TH might depend on age and baseline BMD and at LS on prior denosumab use. The results suggest that these factors may be relevant for clinical decision making when initiating TPD treatment, although larger studies are needed to confirm these findings.